All NewsBio/Pharma News
All PublicationsPharmTechPharmTech Europe
MarketplaceICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksWhitepapers
Webcasts
All VideosAsk the ExpertBehind The HeadlinesBuy, Sell, HoldDrug Digest VideosDrug Solutions PodcastPeer ExchangeSexy ScienceTech Talk
Conference CoverageConference ListingEvents
Subscribe
AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality Systems
Spotlight -
  • Analytics
  • Dosage Forms
  • Drug Development
  • Manufacturing
  • Outsourcing
  • Quality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

    • Webcasts
    • Subscribe

November 2010 Editor's Picks: Products from BinMaster and Silverson Machines

November 17, 2010
By Pharmaceutical Technology Editors
Article

Equipment and Processing Report

Equipment and Processing ReportEquipment and Processing Report-11-17-2010
Volume 0
Issue 0

PharmTech's monthly newsletter, Equipment and Processing Report, reviews the Editor's Picks for the November 2010 edition from BinMaster and Silverson Machines.

BinMaster
Process connection provides long service life

BinMaster’s (Lincoln, NE) stainless-steel process connection for the BMRX and MAXIMA+ rotary level indicators is designed especially to withstand corrosive materials. The device fits into existing 1.25- and 1.5-in. standard process connections and can be installed easily without special fittings or adapters. The solid stainless-steel construction of the process connection is designed to be stronger and to last longer than the normal connection on a standard rotary, according to the company. Rotaries are appropriate for detecting the level of material in bins, hoppers, and silos to ensure continuous operation or manage inventory.

Operators can use a rotary with the process connection with three-vane, two-vane, insertable, and bayonet-style stainless-steel paddles. BinMaster’s insertable paddle collapses to fit through a standard 1.5- or 1.25-in. opening, and the rotary can be installed without entering the bin. Employees choose the proper paddle according to the type and weight of the material.

Silverson Machines
Machine produces agglomerate-free mixes

The Flashmix from Silverson Machines (East Longmeadow, MA) is a high-shear mixer designed for powder–liquid mixing. The machine brings liquids and powders together in the high-shear region of its precision-engineered rotor–stator workhead assembly, thus subjecting materials to focused high shear to create an agglomerate-free dispersion. The mixer’s modified rotor–stator workhead also boosts its pumping performance, thus eliminating the need for an additional pump.

The Flashmix machine wets out powders at rates as high as 250 lb/min. Operators do not have to adjust the mixer’s valves to balance powder incorporation and liquid-flow rates as viscosity rises. The mixer incorporates a clean-in-place loop intended to simplify operation. Users can install the machine in an existing process easily, and the unit has a lower power requirement than competing mixers because it does not need an additional feed pump.

Articles in this issue

BinMaster_RotaryWEB-694894-1408636457174.jpg
November 2010 Editor's Picks: Products from BinMaster and Silverson Machines
Product Differentiation: The Prize for the Winning Drug–Device Combination
Prout-Pharma-cleanzoneWEB-691057-1408638858233.jpg
A Comparison of Polymeric Flooring and Disposable Mats in Pharmaceutical Cleanrooms
Recent Videos
Behind the Headlines, Episode 18
Drug Digest: Patient Preference Drives Solid Dosage Trends
Behind the Headlines, Episode 17
Related Content

Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept. | Image Credit: © Dilok - stock.adobe.com

EIT Health Ireland–UK Expands European Network with Three New Members

Patrick Lavery
June 19th 2025
Article

NIBRT, Firefinch, and eg technology will join the center, adding to its collective of healthcare innovators.


Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.


Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

FDA Voucher Program Provides Shorter Drug Application Review Time

Susan Haigney
June 18th 2025
Article

The Commissioner’s National Priority Voucher can be used by drug developers to participate in a novel priority program for shortened drug approval review time.


Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
April 30th 2024
Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.


Stainless steel door and walls, clean room | Image Credit: © Alexandr - stock.adobe.com

New Company Chrysalis Launches After Acquisition of Cleanroom Assets

Patrick Lavery
June 17th 2025
Article

Chrysalis lists among its partners early-stage biotechnology companies, contract research organizations, top-10 pharmaceutical firms, and various other life sciences stakeholders.


South San Francisco, CA, USA - February 24, 2021: Closeup of a AstraZeneca building corporate office, a British-Swedish pharmaceutical, biotechnology company with its headquarters in Cambridge, England | Image Credit: © Valeriya Zankovych - stock.adobe.com

AstraZeneca Partners on AI-Enabled Research with CSPC Pharmaceuticals

Patrick Lavery
June 13th 2025
Article

The collaboration will focus on identifying pre-clinical candidates for high-priority targets, including a small molecule oral therapy for immunological diseases.

Related Content

Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept. | Image Credit: © Dilok - stock.adobe.com

EIT Health Ireland–UK Expands European Network with Three New Members

Patrick Lavery
June 19th 2025
Article

NIBRT, Firefinch, and eg technology will join the center, adding to its collective of healthcare innovators.


Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.


Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

FDA Voucher Program Provides Shorter Drug Application Review Time

Susan Haigney
June 18th 2025
Article

The Commissioner’s National Priority Voucher can be used by drug developers to participate in a novel priority program for shortened drug approval review time.


Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
April 30th 2024
Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.


Stainless steel door and walls, clean room | Image Credit: © Alexandr - stock.adobe.com

New Company Chrysalis Launches After Acquisition of Cleanroom Assets

Patrick Lavery
June 17th 2025
Article

Chrysalis lists among its partners early-stage biotechnology companies, contract research organizations, top-10 pharmaceutical firms, and various other life sciences stakeholders.


South San Francisco, CA, USA - February 24, 2021: Closeup of a AstraZeneca building corporate office, a British-Swedish pharmaceutical, biotechnology company with its headquarters in Cambridge, England | Image Credit: © Valeriya Zankovych - stock.adobe.com

AstraZeneca Partners on AI-Enabled Research with CSPC Pharmaceuticals

Patrick Lavery
June 13th 2025
Article

The collaboration will focus on identifying pre-clinical candidates for high-priority targets, including a small molecule oral therapy for immunological diseases.

About Us
Advertise
Contact Us
Editorial Info
Editorial Advisory Board
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.